Inpatient Evaluation of an Automated Closed-Loop Control-to-Range System

PHASE1CompletedINTERVENTIONAL
Enrollment

57

Participants

Timeline

Start Date

March 31, 2011

Primary Completion Date

August 31, 2012

Study Completion Date

August 31, 2012

Conditions
Type 1 Diabetes
Interventions
DEVICE

Control-to-Range Automated Insulin Management System

The devices that will be used in the Closed-Loop Control System are standardized across all study sites and include the DexCom Seven Plus Continuous Glucose Monitor (CGM), the OmniPod insulin pump, and the FreeStyle blood glucose meter. The Closed-Loop Control System will be used during all 3 admission visits.

Trial Locations (7)

22908

University of Virginia, Charlottesville

34295

Montpellier University Hospital, Montpellier

49202

Schneider Children's Medical Center of Israel, Petah Tikva

80045

University of Colorado Health Sciences Center- Barbara Davis, Aurora

93105

Sansum Diabetes Research Institute, Santa Barbara

93106

University of Padova, Padua

94305

Stanford University, Stanford

All Listed Sponsors
lead

Jaeb Center for Health Research

OTHER